CHC – The Cancer & Hematology Centers

Breast

Name of this trial: INAVO123 What type of cancer is this for? Breast Cancer Who is this trial for? Patients with locally advanced or metastatic breast cancer. What biomarkers are involved? PIK3CA-positive, ER+, HER2- What is the National Clinical Trial #? NCT06790693  Brief summary of this trial: This is a blinded trial that consists of